Read our guides to learn best practices on how to eliminate issues and risks and launch high-quality, compliant products to market.
The quality management system regulation (QMSR) is important because it defines the quality system framework that medical device manufacturers must follow to meet FDA requirements. It also brings the U.S. regulatory framework closer to ISO 13485:2016, which can help manufacturers manage quality processes across multiple markets with a more consistent approach.
For medical device manufacturers, compliance affects activities throughout new product development (NPD), new product introduction (NPI), manufacturing, supplier management, and postmarket quality. Companies need reliable processes for controlling documents, tracking changes, maintaining quality records, managing nonconformances, and responding to product or process issues.
The move toward ISO 13485 alignment has been an important issue for medical device manufacturers because quality documentation must be implemented and maintained, not simply created. Connected product and quality records can make it easier to demonstrate consistent adherence to approved product development procedures.
The previous quality system regulation (QSR) established FDA quality system requirements under 21 CFR Part 820. QMSR modernizes this framework by incorporating ISO 13485:2016 and adding or retaining FDA-specific provisions needed for U.S. regulatory oversight.
This change means manufacturers should evaluate their existing quality management system (QMS) processes against the new regulatory framework and perform a gap assessment. Organizations that already follow ISO 13485 may have a useful foundation, but they still need to account for FDA-specific requirements and determine whether their procedures, records, terminology, and processes meet QMSR requirements.
The transition is particularly relevant to companies that previously maintained separate approaches for FDA and ISO compliance. A more harmonized framework can support consistency, but manufacturers still need effective document control, training, quality processes, and traceability to demonstrate compliance.
QMSR compliance is directly related to quality management system (QMS) and product lifecycle management (PLM) processes. Medical device quality events rarely exist independently of the product record. A nonconformance, corrective and preventive action (CAPA), supplier issue, customer complaint, or design change may relate to specific parts, assemblies, requirements, drawings, specifications, or product revisions.
Connecting QMS and PLM information helps organizations maintain traceability between product data and quality records. A connected approach can give engineering, quality, regulatory, operations, and supply chain teams access to controlled information while supporting design controls, change management, and audit readiness. Product-centric QMS processes also link CAPAs and other quality records to the bill of materials (BOM) and related product information.
During NPD and NPI, these connections help teams manage requirements, design outputs, approvals, product changes, and quality activities before a device reaches production. Once the device is released, the same traceability can help teams evaluate quality issues and determine which products, components, suppliers, or revisions are affected.
Bill of materials (BOM) management provides an important product foundation for medical device companies. The BOM identifies the components and assemblies that make up a product, while associated records can include drawings, specifications, approved manufacturer information, software, and other controlled product data.
When a quality issue requires a design or manufacturing change, teams need to determine exactly which products and revisions are affected. Controlled engineering change processes can help ensure that updates are properly reviewed, approved, documented, and communicated before implementation.
This connection between product and quality information is particularly useful for medical device manufacturers because traditional document-focused QMS approaches may not effectively manage complex product structures. Connecting the complete product record with quality processes can improve traceability across design, quality, operations, and the supply chain.
Quality processes under QMSR should help manufacturers identify problems, investigate their causes, control risk, and improve products and processes. CAPA, nonconformance management, complaints, supplier quality, audits, and other processes can provide information that helps organizations identify recurring or systemic problems.
A closed-loop CAPA process connects an identified issue to investigation, corrective action, implementation, and effectiveness review. When CAPA information is linked to the affected product records, teams have additional context to determine the scope of an issue and make appropriate changes. Effective CAPA processes have long been an important part of medical device quality management and ISO 13485 compliance.
The FDA’s quality management system regulation (QMSR) became effective on February 2, 2026. Medical device manufacturers subject to 21 CFR Part 820 should ensure their quality systems meet the applicable QMSR requirements.
QMSR is an FDA regulation that incorporates ISO 13485:2016 by reference and also includes FDA-specific requirements. ISO 13485 is an international quality management system standard for medical devices, so the two frameworks are closely aligned but are not interchangeable.
Yes, QMSR amended the previous FDA quality system regulation framework in 21 CFR Part 820. The revised regulation aligns FDA requirements more closely with ISO 13485:2016 while preserving the requirements mandated by U.S. law.
PLM and QMS software can help organizations control product records, quality documentation, approvals, change processes, CAPAs, training records, and other regulated information. Connecting quality records with parts, BOMs, specifications, and product revisions can also improve traceability and make information easier to retrieve during reviews and audits by centralizing all associated information.
